3,134 karma · joined June 16, 2015
You're right about the sufficient sample size.
I think it would be more reasonable to call someone a 3 -sigma dev (someone 3 standard deviations above the mean. These would exist because that's how stats work)
This sounds kinda like a SPAC tbh.
Would you feel entitled to attending such social gatherings, even if your house rules are so vastly different than everyone else's they dissuade anyone from coming?
Also, anthropomorphizing, China is not my friend. More like arch rival, perhaps even nemesis. Canada can come over whenever.
Another thought I had (not completely fleshed out)... Federal student loans could help cap tuition costs somewhat like medicaid/medicare. The fed offers a fixed amount per semester (say $4k) to each student. The catch is that a uni can only accept fed loans if their tuition is fixed at the cap. (i believe this is how medicare negotiates reasonable prices for meds - "if you want to accept medicare here is what we will pay for Rx, and it's all or nothing").
> From a sales tracking perspective, books are published in multiple formats, each with different ISBNs. I wrote one novel, but from a title count POV I actually published 4 books: hardcover, paperback, ebook, and audiobook. Other books have even more formats (mass market version, movie tie-in editions, etc.) and because they all have different ISBNs, they all have different sales figures.
I would like to see stats that collapse across different versions of (largely) the same text (including new versions or editions of text books, and re-releases that include some special commentary, etc.)
Including a city in the domain seems like it unnecessarily complicates things. If the goal is to provide free access to a more permanent online "identity", people shouldn't be forced to change it when they move.
Recently SANDAG approved a $160 billion dollar Transit Plan. That would equate to $110k per resident if we paid out of pocket; hopefully they can do some financial voodoo so that's not the case.
A few weeks ago SANDAG officials were forced to withdrawal the most controversial part of their plan, a mileage tax that would tax San Diegans for every mile they drive (obviously very unpopular among residents). But, this tax was the main source of funding for the $163B Regional Transportation Plan, so they are forced to find a new funding mechanism. I'm curious what they will come up with.
1. https://www.roland.com/RolandComSite/media/uk/images/article...
2. https://delicious-audio.com/wp-content/uploads//2016/01/Iban...
So there's a small benefit to using antibody treatment. To me suggests that Abeta is a good target, but antibodies are not a sufficient Rx.
Have you seen a brain at BRAAK stage 4-6?
"synapse loss" is a better correlate for dementia because, obviously. But synapse loss is the outcome of the disease, not the cause of the disease.
(2) Amyloid plaques are not the only thing that causes dementia. However genuine AD diagnoses are confirmed post mortem via autopsy and are typically assigned a BRAAK score (most large scale studies require plaque confirmation for cohort inclusion; i.e. AD definitionally requires amyloid presence).
(3) From the large datasets I've worked with, BRAAK score and AD age of onset are HIGHLY correlated. I'm genuinely curious to hear what biomarkers are more correlated.
(4) What is clear-er?
(5) Agree LOAD and EOAD are not identical diseases.
With regard to evidence, the article mentions APP gene variant causes early onset AD; but there is another variant in the APOE gene that is the strongest genetic risk factor in late-onset AD. This gene too is in the Abeta buildup pathway.
With that said, I think that NIH study sections allocating AD research funding should not give preference to a particular molecule or theory. If the Abeta hypothesis is indeed the most compelling, grants focused on Abeta topics should naturally be stronger. They shouldn't need any additional bias to stand out.